steroid
compound
expect
dual
function
block
host
inflamm
merscov
replic
screen
chemic
librari
within
librari
ciclesonid
inhal
corticosteroid
suppress
human
coronaviru
replic
cultur
cell
suppress
replic
respiratori
syncyti
viru
influenza
viru
effect
concentr
ciclesonid
block
caus
replic
ec
eleventh
consecut
merscov
passag
presenc
ciclesonid
resist
mutat
gener
result
amino
acid
substitut
nonstructur
protein
nsp
identifi
use
revers
genet
recombin
viru
mutat
also
resist
ciclesonid
suppress
viral
replic
observ
suggest
effect
ciclesonid
specif
coronaviru
suggest
candid
drug
treatment
patient
suffer
mer
authorfund
right
reserv
reus
allow
without
permiss
outbreak
began
decemb
wuhan
china
caus
viru
rapidli
spread
countri
februari
number
infect
patient
exce
death
toll
exce
sever
drug
includ
lopinavir
remdesivir
chloroquin
report
presum
effect
treat
diseas
system
treatment
corticosteroid
contraind
sever
pneumonia
caus
virus
merscov
sarscov
steroid
suppress
innat
immun
system
result
increas
viral
replic
fact
sar
mer
treatment
corticosteroid
associ
increas
mortal
present
studi
reconsid
use
inhal
corticosteroid
exclud
treatment
pneumonia
caus
coronaviru
steroid
compound
expect
dual
function
block
coronaviru
replic
host
inflamm
screen
chemic
librari
cytopath
effect
caus
merscov
infect
measur
evalu
viral
replic
four
steroid
compound
ciclesonid
mometason
furoat
mifepriston
algeston
acetophenid
confer
greater
cell
surviv
rate
fig
next
concentrationdepend
viral
growth
suppress
drug
cytotox
assess
ciclesonid
exhibit
low
cytotox
potent
suppress
viral
growth
fig
cortison
prednisolon
commonli
use
system
steroid
treatment
dexamethason
strong
immunosuppress
effect
fluticason
commonli
use
inhal
steroid
suppress
viral
growth
fig
antivir
effect
steroid
variou
speci
virus
test
quantifi
propag
viru
cultur
medium
ciclesonid
mometason
also
suppress
replic
coronavirus
sarscov
replic
rs
viru
influenza
viru
fig
addit
ciclesonid
slightli
significantli
inhibit
rubella
viru
posit
strand
rna
genom
replic
fig
suggest
ciclesonid
interact
replic
site
positivestrand
rna
viru
intracellularli
identifi
drug
target
viru
replic
conduct
consecut
merscov
passag
presenc
ciclesonid
mometason
mutant
viru
develop
resist
ciclesonid
gener
fig
resist
viru
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mometason
gener
nextgener
sequenc
identifi
amino
acid
substitut
refer
sequenc
nonstructur
protein
coronaviru
endoribonucleas
predict
mechan
viral
resist
ciclesonid
recombin
viru
carri
amino
acid
substitut
gener
parent
merscovemc
strain
reemcmer
bac
revers
genet
system
overcam
antivir
effect
ciclesonid
fig
interestingli
mutant
viru
inhibit
mometason
suggest
antivir
target
mometason
differ
ciclesonid
next
effect
ciclesonid
infect
evalu
cell
infect
authent
presenc
steroid
inhibitor
h
postinfect
cellular
rna
isol
realtim
pcr
conduct
quantifi
amount
viral
rna
ciclesonid
mometason
suppress
viral
replic
similar
efficaci
lopinavir
fig
comparison
viral
cell
entri
inhibitor
test
substanti
reduc
viral
rna
level
nafamostat
camostat
modest
antivir
effect
suggest
primarili
util
cathepsinendosom
pathway
cell
entri
rather
surfac
pathway
enter
cell
consist
recent
studi
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
copyright
holder
preprint
peerreview
th
http
doi
biorxiv
preprint
rna
copi
log
rna
cell
hpi
cell
viabil
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
th
http
doi
biorxiv
preprint
